Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance

Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type 11 Due to a Mutation in Plasmid-Borne blakpc-2 to blakpc-33, in Henan, China

(2021) Debao Li et al.   Infection and Drug Resistance

Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies

(2021) Stefano Di Bella et al.   Journal of Global Antimicrobial Resistance

Klebsiella pneumoniae KPC producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene

(2020) Elisa Antinori et al.   CLINICAL MICROBIOLOGY AND INFECTION

Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2

(2019) Peera Hemarajata et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam

(2019) Galani Irene et al.   CLINICAL MICROBIOLOGY AND INFECTION

KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues

(2019) Alberto Antonelli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime/avibactam

(2019) Carolina Venditti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Patient-to-patient transmission of KPC variants with reduced ceftazidime-avibactam susceptibility

(2019) L. Silvia Munoz-Price et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo

(2019) Stephan Göttig et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

(2019) P. Zhang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae

(2018) Mario Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

(2018) Jesús Rodríguez-Baño et al.   CLINICAL MICROBIOLOGY REVIEWS

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment

(2018) Paolo Gaibani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

(2018) Antoni Torres et al.   LANCET INFECTIOUS DISEASES

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype

(2018) Mariana Castanheira et al.   mSphere

Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?

(2018) Despoina Koulenti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Public health burden of antimicrobial resistance in Europe

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature

(2017) Ryan K. Shields et al.   Open Forum Infectious Diseases

Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program

(2016) Elizabeth Temkin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

(2016) Ryan K. Shields et al.   CLINICAL INFECTIOUS DISEASES

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

(2015) Romney M. Humphries et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroSelection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase

(2015) David M. Livermore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of ceftazidime/avibactam against isogenic strains ofEscherichia colicontaining KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop

(2015) Marisa L. Winkler et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial resistance: a global multifaceted phenomenon

(2015) Francesca Prestinaci et al.   Pathogens and Global Health

Multiplex real-time PCR probe-based for identification of strains producing: OXA48, VIM, KPC and NDM

(2014) Marco Favaro et al.   WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY

P70 Detection of plasmid mediated KPC-producing Klebsiella pneumo-niae in Ottawa, Canada: evidence of intra-hospital transmission

(2009) D. Goldfarb et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Genetic Structures at the Origin of Acquisition of the  -Lactamase blaKPC Gene

(2008) T. Naas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY